Bridgeway Capital Management’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $160K | Hold |
|
|||||
|
2025
Q2 | $188K | Hold |
|
|||||
|
2025
Q1 | $200K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $8.97K | Sell |
|
|||||
|
2024
Q2 | $65.2K | Hold |
|
|||||
|
2024
Q1 | $97.9K | Sell |
|
|||||
|
2023
Q4 | $150K | Sell |
|
|||||
|
2023
Q3 | $369K | Buy |
|
|||||
|
2023
Q2 | $479K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $225K | Hold |
|
|||||
|
2022
Q1 | $452K | Sell |
|
|||||
|
2021
Q4 | $2.38M | Sell |
|
|||||
|
2021
Q3 | $1.73M | Sell |
|
|||||
|
2021
Q2 | $1.22M | Sell |
|
|||||
|
2021
Q1 | $1.4M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $218K | Sell |
|
|||||
|
2019
Q4 | $313K | Buy |
|
|||||
|
2019
Q3 | $137K | Buy |
|